Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health-related quality of life in locally advanced rectal cancer: a prospective phase II CRAB trial Cover

.blurhash-client-img { display: none !important; }

Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health-related quality of life in locally advanced rectal cancer: a prospective phase II CRAB trial

Radiology and Oncology

Volume 54 (2020): Issue 4 (December 2020)

By: Vaneja Velenik, Vesna Zadnik, Mirko Omejc, Jan Grosek and Mojca Tuta

Open Access

|Aug 2020

Authors

Vaneja Velenik

vvelenik@onko-i.si

Division of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia

Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

Vesna Zadnik

Division of Epidemiology, Institute of Oncology, Ljubljana, Slovenia

Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

Mirko Omejc

Division of Surgery, University Medical Center Ljubljana, Ljubljana, Slovenia

Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

Jan Grosek

Division of Surgery, University Medical Center Ljubljana, Ljubljana, Slovenia

Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

Mojca Tuta

Division of Radiology, Institute of Oncology, Ljubljana, Slovenia

Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2020-0043 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 461 - 469

Submitted on: Mar 1, 2020

|

Accepted on: Jun 13, 2020

|

Published on: Aug 1, 2020

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

preoperative chemoradiotherapy

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2020 Vaneja Velenik, Vesna Zadnik, Mirko Omejc, Jan Grosek, Mojca Tuta, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 54 (2020): Issue 4 (December 2020)Next article